Mentoring clinical investigators in patient-oriented research on substance use and HIV

项目摘要/摘要 变性人妇女是世界上艾滋病毒感染率最高的群体之一，也是全世界艾滋病毒风险最高的群体 美国和巴西。变性人女性经历了多重耻辱，使她们获得 以及坚持医疗保健，导致跨部门的耻辱和负面的健康后果。交叉性 是一种批判性理论，它认为权力关系构建了我们的视角和经验，并具有 有可能为变性人社区的研究提供有意义的信息，以及指导方法 跨越差异。使用交叉性框架的新应用，Jae Sevelius博士，助理 加州大学旧金山分校的驻校教授提出了(1)自己的职业规划 将扩大其研究范围以包括物质使用和实施科学的发展，(2)计划 扩大他们的研究计划，为学员提供充足的培训机会；以及(3)计划 提供指导，重点支持在医学(URM)中任职人数不足和/或 启动一项研究方案，侧重于解决性少数群体和性别少数群体之间的健康差距 (SGM)。他们以社区为基础、以病人为导向的研究侧重于风险和保护的调查 变性人社区的因素以及污名、歧视和健康相关因素之间的关系 行为和结果。塞维利乌斯博士一直致力于开发、实施和 评价可降低健康风险的健康促进干预措施，包括艾滋病毒传播和 获得，并通过行为改变、社区规划和增加 获得文化上适当的卫生保健。他们对跨物种的研究和科学贡献 性别肯定模式在变性人健康和性别健康领域得到国内和国际认可 预防和治疗艾滋病毒。学员培训将利用Sevelius博士的基础设施和资源 正在进行的干预研究及其与多学科和国际研究人员的合作 国内和巴西的艾滋病毒、药物使用和变性人健康领域。为了扩展 在他们的指导计划的范围内，他们建议推出一个基于小组的远程指导计划， 促进写作与他们的指导者加强，并在以下领域产生奖学金和培训 跨部门辅导。最后，塞维利乌斯博士建议进行K24资助的研究，将 作为学员的培训工具，通过(1)扩展他们的研究经验来发展他们的研究 和学术，将变性人妇女使用物质的特征纳入 (2)培养实施科学方面的专门知识，以确定艾滋病毒治疗的最佳做法 在跨性别人群中实施有效的艾滋病毒预防干预措施 物质，以及(3)获得评估交叉污名的经验并将其与 巴西的变性人。

PROJECT SUMMARY/ABSTRACT Transgender women have some of the highest rates of HIV in the world and are the highest HIV risk group in the United States and Brazil. Transgender women experience multiple stigmas that complicate their access to and adherence to healthcare, resulting in intersectional stigma and negative health outcomes. Intersectionality is a critical theory which posits that power relations construct our perspectives and experiences and has the potential to meaningfully inform research with transgender communities as well as an approach to mentorship across differences. Using novel applications of the framework of intersectionality, Dr. Jae Sevelius, Associate Professor in Residence, University of California, San Francisco, proposes (1) a plan for their own career development that will expand their research to include substance use and implementation science, (2) a plan to expand their program of research to provide ample training opportunities for mentees, and (3) a plan to provide mentoring focused on supporting mentees who are underrepresented in medicine (URM) and/or are launching a program of research focused on addressing health disparities among sexual and gender minorities (SGM). Their community-based, patient-oriented research is focused on the investigation of risk and protective factors in transgender communities and the relationship between stigma, discrimination, and health-related behaviors and outcomes. Dr. Sevelius' efforts have been dedicated to developing, implementing, and evaluating health promotion interventions that decrease health risks, including HIV transmission and acquisition, and improve treatment through behavioral changes, community programming, and increased access to culturally appropriate health care. Their research and scientific contribution of the trans-specific Model of Gender Affirmation is recognized nationally and internationally in the field of transgender health and HIV prevention and treatment. Mentee training will leverage the infrastructure and resources of Dr. Sevelius' ongoing intervention research and their collaborations with multidisciplinary and international researchers in the areas of HIV, substance use, and transgender health domestically and in Brazil. In order to expand the scope of their mentoring program, they propose to launch a group-based distance mentoring program, conduct facilitated writing intensives with their mentees, and produce scholarship and training in the area of intersectional mentoring. Lastly, Dr. Sevelius proposes to conduct K24 supported research studies that will serve as training vehicles for mentees and develop their research by (1) expanding their research experience and scholarship to include the characterization of substance use among transgender women within the context of HIV treatment, (2) cultivating expertise in implementation science to identify best practices for implementation of efficacious HIV prevention interventions among transgender populations who use substances, and (3) gaining experience assessing and contextualizing intersectional stigma among transgender populations in Brazil.